Literature DB >> 11249860

Inflammation is probably not a prerequisite for renal interstitial fibrosis in normoglycemic obese rats.

S Lavaud1, B Poirier, C Mandet, M F Bélair, T Irinopoulou, D Heudes, R Bazin, J Bariéty, I Myara, J Chevalier.   

Abstract

We examined the role of inflammation in the development of renal interstitial fibrosis in Zucker obese rats, which rapidly present kidney lesions in the absence of hypertension and hyperglycemia. Type I and III collagens were quantified using a polarized light and computer-assisted image analyzer. The expression of mRNA encoding matrix components, adhesion molecules, chemokines, and growth factors was followed by RT-PCR. The presence of synthesized proteins as well as lymphocytes and macrophages was determined by immunohistochemistry. Interstitial fibrosis developed in two phases. The first phase occurred as early as 3 mo and resulted from a neosynthesis of type III collagen and fibronectin and a reduction of extracellular matrix catabolism, in parallel with an overexpression of transforming growth factor-beta(1) and in the absence of any lymphocyte or macrophage infiltration. After 6 mo, interstitial fibrosis worsened with a large accumulation of type I collagen, concomitantly with a large macrophage infiltration. Thus inflammation cannot explain the onset of interstitial fibrosis that developed in young, insulinoresistant, normoglycemic, obese Zucker rats but aggravated this process afterward.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11249860     DOI: 10.1152/ajprenal.2001.280.4.F683

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  7 in total

1.  Localisation and phenotypical characterisation of collagen-producing cells in TGF-beta 1-induced renal interstitial fibrosis.

Authors:  Qing Chai; Søren Krag; Song Chai; Thomas Ledet; Lise Wogensen
Journal:  Histochem Cell Biol       Date:  2003-04-02       Impact factor: 4.304

Review 2.  Dyslipoproteinemia and impairment of renal function in diabetic kidney disease: an analysis of animal studies, observational studies, and clinical trials.

Authors:  Chi-Chih Hung; Jer-Chia Tsai; Hung-Tien Kuo; Jer-Ming Chang; Shang-Jyh Hwang; Hung-Chun Chen
Journal:  Rev Diabet Stud       Date:  2013-08-10

3.  Antifibrotic effects of pioglitazone on the kidney in a rat model of type 2 diabetes mellitus.

Authors:  Jorge E Toblli; Monica G Ferrini; Gabriel Cao; Dolores Vernet; Margarita Angerosa; Nestor F Gonzalez-Cadavid
Journal:  Nephrol Dial Transplant       Date:  2009-03-17       Impact factor: 5.992

4.  Impact of obesity on renal structure and function in the presence and absence of hypertension: evidence from melanocortin-4 receptor-deficient mice.

Authors:  Jussara M do Carmo; Lakshmi S Tallam; John V Roberts; Elizabeth L Brandon; John Biglane; Alexandre A da Silva; John E Hall
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-07-15       Impact factor: 3.619

Review 5.  Diabetic fibrosis.

Authors:  Izabela Tuleta; Nikolaos G Frangogiannis
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2020-12-28       Impact factor: 5.187

6.  Tubulointerstitial macrophage accumulation is regulated by sequentially expressed osteopontin and macrophage colony-stimulating factor: implication for the role of atorvastatin.

Authors:  Shaojiang Tian; Guohua Ding; Ruhan Jia; Guili Chu
Journal:  Mediators Inflamm       Date:  2006       Impact factor: 4.711

7.  Inhibition of a novel fibrogenic factor Tl1a reverses established colonic fibrosis.

Authors:  D Q Shih; L Zheng; X Zhang; H Zhang; Y Kanazawa; R Ichikawa; K L Wallace; J Chen; C Pothoulakis; H W Koon; S R Targan
Journal:  Mucosal Immunol       Date:  2014-05-21       Impact factor: 7.313

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.